Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer

Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes

NCT07272109 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas

NCT03779464 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer

NCT02017015 ·Status: COMPLETED ·Phase: PHASE2

Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer

NCT05634564 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer

NCT04498689 ·Status: UNKNOWN ·Phase: PHASE2

Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection

NCT02023021 ·Status: COMPLETED ·Phase: PHASE2

Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

NCT02506842 ·Status: UNKNOWN ·Phase: PHASE3

Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy

NCT04707118 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer

NCT02272738 ·Status: COMPLETED ·Phase: PHASE1

Nab-Paclitaxel and Gemcitabine Plus Camrelizumab and Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma

NCT04365049 ·Status: UNKNOWN

Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer

NCT06051851 ·Status: RECRUITING ·Phase: PHASE2

Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer

NCT02283372 ·Status: COMPLETED ·Phase: PHASE1

Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer

NCT03636308 ·Status: UNKNOWN ·Phase: PHASE2

Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer

NCT06250972 ·Status: RECRUITING ·Phase: PHASE3

First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients

NCT06313970 ·Status: RECRUITING ·Phase: PHASE2

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

NCT05298020 ·Status: UNKNOWN ·Phase: PHASE2

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

NCT04233866 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer

NCT04216758 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma

NCT03633734 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer

NCT03415802 ·Status: COMPLETED ·Phase: PHASE2

DDP ip Combined With AG in PDAC With Peritoneal Metastasis

NCT05222204 ·Status: COMPLETED ·Phase: PHASE2

SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer

NCT05185869 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.

NCT05497778 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma

NCT02993731 ·Status: COMPLETED ·Phase: PHASE3

The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients

NCT05168527 ·Status: UNKNOWN ·Phase: PHASE2